Food and Drug Administration (FDA) Approves Chorulon for Finfish

FDA announced its final ruling in a Federal Register notice dated September 7, 1999 amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Intervet, Inc.  The supplemental NADA provides for intramuscular use of chorionic gonadotropin, a freeze-dried powder reconstitued for intramuscular injection in male and female brood finfish as an aid in improving spawning function.  The regulations are also amended to establish an acceptable daily intake (ADI) for total gonadotropins.

For further information you may contact Joan C. Gotthardt, Center for Veterinary Medicine (HFV-130), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, Tel. 301-827-7571.

If you would like a copy of the Federal Register notice, Contact the NAA office.
111 W. Washington Street, Ste. 1, Charles Town, WV 25414-1529 Tel. 304-728-2167 Fax: 304-728-2196.  Email: naa@intrepid.net